Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Evolving therapeutic concepts in prostate cancer based on genome-wide analyses (Review).

Georgi B, Korzeniewski N, Hadaschik B, Grüllich C, Roth W, Sültmann H, Pahernik S, Hohenfellner M, Duensing S.

Int J Oncol. 2014 Oct;45(4):1337-44. doi: 10.3892/ijo.2014.2567. Epub 2014 Jul 28.

PMID:
25070358
[PubMed - in process]
2.

Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation.

Ridder K, Keller S, Dams M, Rupp AK, Schlaudraff J, Turco DD, Starmann J, Macas J, Karpova D, Devraj K, Depboylu C, Landfried B, Arnold B, Plate KH, Höglinger G, Sültmann H, Altevogt P, Momma S.

PLoS Biol. 2014 Jun 3;12(6):e1001874. doi: 10.1371/journal.pbio.1001874. eCollection 2014 Jun.

PMID:
24893313
[PubMed - in process]
Free PMC Article
3.

The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.

Hussong M, Börno ST, Kerick M, Wunderlich A, Franz A, Sültmann H, Timmermann B, Lehrach H, Hirsch-Kauffmann M, Schweiger MR.

Cell Death Dis. 2014 Apr 24;5:e1195. doi: 10.1038/cddis.2014.157.

PMID:
24763052
[PubMed - in process]
Free PMC Article
4.

Long noncoding RNA: "LNCs" to cancer.

Sültmann H, Diederichs S.

Eur Urol. 2014 Jun;65(6):1152-3. doi: 10.1016/j.eururo.2014.01.032. Epub 2014 Jan 31. No abstract available.

PMID:
24508069
[PubMed - in process]
5.

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.

Schirmer U, Doberstein K, Rupp AK, Bretz NP, Wuttig D, Kiefel H, Breunig C, Fiegl H, Müller-Holzner E, Zeillinger R, Schuster E, Zeimet AG, Sültmann H, Altevogt P.

Oncotarget. 2014 Jan 30;5(2):462-72.

PMID:
24497324
[PubMed - in process]
Free PMC Article
6.

Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S.

Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19.

PMID:
24361467
[PubMed - indexed for MEDLINE]
7.

[Urology in the concept of comprehensive cancer centers].

Hadaschik B, Pahernik S, Grüllich C, Sültmann H, Jäger D, von Kalle C, Duensing S, Hohenfellner M.

Urologe A. 2013 Sep;52(9):1283-9. doi: 10.1007/s00120-013-3313-3. Review. German.

PMID:
23942742
[PubMed - indexed for MEDLINE]
8.

ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer.

Kacprzyk LA, Laible M, Andrasiuk T, Brase JC, Börno ST, Fälth M, Kuner R, Lehrach H, Schweiger MR, Sültmann H.

PLoS One. 2013;8(3):e59976. doi: 10.1371/journal.pone.0059976. Epub 2013 Mar 29.

PMID:
23555854
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue.

Hellwinkel OJ, Sellier C, Sylvester YM, Brase JC, Isbarn H, Erbersdobler A, Steuber T, Sültmann H, Schlomm T, Wagner C.

Int J Mol Sci. 2013 Mar 4;14(3):5239-49. doi: 10.3390/ijms14035239.

PMID:
23459235
[PubMed]
Free PMC Article
10.

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, Wuttig D, Warnatz HJ, Stehr H, Rausch T, Jäger N, Gu L, Bogatyrova O, Stütz AM, Claus R, Eils J, Eils R, Gerhäuser C, Huang PH, Hutter B, Kabbe R, Lawerenz C, Radomski S, Bartholomae CC, Fälth M, Gade S, Schmidt M, Amschler N, Haß T, Galal R, Gjoni J, Kuner R, Baer C, Masser S, von Kalle C, Zichner T, Benes V, Raeder B, Mader M, Amstislavskiy V, Avci M, Lehrach H, Parkhomchuk D, Sultan M, Burkhardt L, Graefen M, Huland H, Kluth M, Krohn A, Sirma H, Stumm L, Steurer S, Grupp K, Sültmann H, Sauter G, Plass C, Brors B, Yaspo ML, Korbel JO, Schlomm T.

Cancer Cell. 2013 Feb 11;23(2):159-70. doi: 10.1016/j.ccr.2013.01.002.

PMID:
23410972
[PubMed - indexed for MEDLINE]
Free Article
11.

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients.

Kaduthanam S, Gade S, Meister M, Brase JC, Johannes M, Dienemann H, Warth A, Schnabel PA, Herth FJ, Sültmann H, Muley T, Kuner R.

Lung Cancer. 2013 May;80(2):223-7. doi: 10.1016/j.lungcan.2013.01.013. Epub 2013 Feb 11.

PMID:
23410826
[PubMed - indexed for MEDLINE]
12.

Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.

Massoner P, Kugler KG, Unterberger K, Kuner R, Mueller LA, Fälth M, Schäfer G, Seifarth C, Ecker S, Verdorfer I, Graber A, Sültmann H, Klocker H.

PLoS One. 2013;8(2):e55207. doi: 10.1371/journal.pone.0055207. Epub 2013 Feb 4.

PMID:
23390522
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.

Starmann J, Fälth M, Spindelböck W, Lanz KL, Lackner C, Zatloukal K, Trauner M, Sültmann H.

PLoS One. 2012;7(10):e46584. doi: 10.1371/journal.pone.0046584. Epub 2012 Oct 10.

PMID:
23071592
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.

Kuner R, Fälth M, Pressinotti NC, Brase JC, Puig SB, Metzger J, Gade S, Schäfer G, Bartsch G, Steiner E, Klocker H, Sültmann H.

J Mol Med (Berl). 2013 Feb;91(2):237-48. doi: 10.1007/s00109-012-0949-1. Epub 2012 Sep 4.

PMID:
22945237
[PubMed - indexed for MEDLINE]
15.

Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation.

Börno ST, Fischer A, Kerick M, Fälth M, Laible M, Brase JC, Kuner R, Dahl A, Grimm C, Sayanjali B, Isau M, Röhr C, Wunderlich A, Timmermann B, Claus R, Plass C, Graefen M, Simon R, Demichelis F, Rubin MA, Sauter G, Schlomm T, Sültmann H, Lehrach H, Schweiger MR.

Cancer Discov. 2012 Nov;2(11):1024-35. doi: 10.1158/2159-8290.CD-12-0041. Epub 2012 Aug 28.

PMID:
22930729
[PubMed - indexed for MEDLINE]
16.

microRNA biomarkers in body fluids of prostate cancer patients.

Kuner R, Brase JC, Sültmann H, Wuttig D.

Methods. 2013 Jan;59(1):132-7. doi: 10.1016/j.ymeth.2012.05.004. Epub 2012 May 29.

PMID:
22652624
[PubMed - indexed for MEDLINE]
17.

A simple strand-specific RNA-Seq library preparation protocol combining the Illumina TruSeq RNA and the dUTP methods.

Sultan M, Dökel S, Amstislavskiy V, Wuttig D, Sültmann H, Lehrach H, Yaspo ML.

Biochem Biophys Res Commun. 2012 Jun 15;422(4):643-6. doi: 10.1016/j.bbrc.2012.05.043. Epub 2012 May 15.

PMID:
22609201
[PubMed - indexed for MEDLINE]
Free Article
18.

Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.

Kahn N, Meister M, Eberhardt R, Muley T, Schnabel PA, Bender C, Johannes M, Keitel D, Sültmann H, Herth FJ, Kuner R.

J Thorac Oncol. 2012 Jun;7(6):1001-8. doi: 10.1097/JTO.0b013e31824fe921.

PMID:
22588153
[PubMed - indexed for MEDLINE]
19.

Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.

Ummanni R, Barreto F, Venz S, Scharf C, Barett C, Mannsperger HA, Brase JC, Kuner R, Schlomm T, Sauter G, Sültmann H, Korf U, Bokemeyer C, Walther R, Brümmendorf TH, Balabanov S.

J Proteome Res. 2012 Apr 6;11(4):2452-66. doi: 10.1021/pr201172n. Epub 2012 Mar 28.

PMID:
22424448
[PubMed - indexed for MEDLINE]
20.

Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer.

Gade S, Porzelius C, Fälth M, Brase JC, Wuttig D, Kuner R, Binder H, Sültmann H, Beissbarth T.

BMC Bioinformatics. 2011 Dec 21;12:488. doi: 10.1186/1471-2105-12-488.

PMID:
22188670
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk